Clinical Trials Directory

Trials / Completed

CompletedNCT00640055

Verbal Autopsy to Assess Early Neonatal Death and Stillbirth

Using Verbal Autopsy to Determine Cause of Stillbirths and Early Neonatal Deaths Within the NICHD Global Network

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
NICHD Global Network for Women's and Children's Health · Network
Sex
All
Age
7 Days
Healthy volunteers
Accepted

Summary

The NICHD Global Network (GN) for Women's and Children's Health Research, a multi-site, international research network, provides a unique infrastructure to implement an expanded perinatal verbal autopsy study using the FIRST BREATH trial as its platform. The FIRST BREATH trial is an ongoing study of neonatal resuscitation training in rural community settings within Global Network sites in Central Africa, Asia and Latin America. This study uses a validated VA questionnaire to determine COD of stillbirths and early neonatal deaths among participants in the FIRST BREATH study. We propose to expand the usefulness of perinatal verbal autopsy methodology in two ways. First by assessing whether the Community Coordinator (a non-physician health worker) can assign COD with a high level of concordance comparable to a Physician Panel, and second, whether the FIRST BREATH Birth Attendant can provide as reliable perinatal information as the mother during the VA interview. Our primary hypothesis is that the COD assigned by the FIRST BREATH Community Coordinator will be the same as the COD assigned by the Physician Panel in greater than 70% of early neonatal deaths (ENDs), when both use the same VA and FIRST BREATH data.

Conditions

Interventions

TypeNameDescription
OTHERCoordinatorCoordinator (non-physician) assigned cause of death
OTHERPhysician-assigned cause of deathPhysician (gold standard) cause of death

Timeline

Start date
2007-07-01
Primary completion
2008-05-01
Completion
2008-07-01
First posted
2008-03-20
Last updated
2014-07-31

Locations

4 sites across 4 countries: Guatemala, Pakistan, Republic of the Congo, Zambia

Source: ClinicalTrials.gov record NCT00640055. Inclusion in this directory is not an endorsement.